The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A comparison of CR versus CRi response following CPX-351 treatment of newly diagnosed AML in elderly patients (pts).
Jeffrey E. Lancet
Consultant or Advisory Role - Celator (U)
Research Funding - Celator
Jorge E. Cortes
Consultant or Advisory Role - Celator (U)
Research Funding - Celator
Tibor Kovacsovics
Research Funding - Celator
Donna Hogge
Research Funding - Celator
Jonathan E. Kolitz
Research Funding - Celator
Martin S. Tallman
Research Funding - Celator
Michael Chiarella
Employment or Leadership Position - Celator
Arthur Chin Louie
Employment or Leadership Position - Celator
Stock Ownership - Celator
Eric Jay Feldman
Consultant or Advisory Role - Celator (U)
Research Funding - Celator